(PharmaNewsWire.Com, September 06, 2021 ) According to the new market research report "ePrescribing Market by Product & Services (Solution (Integrated, Standalone), Services(Implementation, Network)),by Delivery Mode (Web & Cloud based, On premise) End User (Hospitals, Physician Offices, Pharmacies), COVID-19 Impact-Global Forecast to 2025" The global ePrescribing market size is projected to reach USD 3.3 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 23.3%.
Factors such as the increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the e-prescribing market. Additionally, the onset of the COVID-19 pandemic has accelerated the use of telemedicine modules and telehealth consultations. This is further driving the adoption of e-prescribing solutions. However, the high cost of deploying e-prescribing solutions, reluctance among healthcare professionals to adopt these solutions, and concerns regarding security and workflow are expected to restrain the growth of this market to a certain extent during the forecast period.
The ePrescribing market is segmented based on the type of product & service, delivery mode, end user, and region. Due to lockdown restrictions and social distancing protocols due to COVID-19 across various countries through the first half of 2020, the market saw an increase in the number of telehealth consultations followed by use of eprescribing solutions to prescribe medicines. Additionally, governments across countries are trying to regulate and expedite the use of ePrescribng functionality with telehealth functionality to avoid unnecessary hospital visits. Hence, the market is expected to show a slight increase in size due to increased adoption of these solutions.
The solutions accounted for the largest share of the ePrescribing market, by type of product & service, in 2019.
Based on product and service, the e-prescribing market is segmented into solutions and services. The solutions segment is further categorized as integrated and standalone solutions, and the services segment is categorized as network, support and maintenance, implementation, and training and education services. In 2019, the solutions segment accounted for the largest share of the e-prescribing market. The large share of the solutions segment can be attributed to the growing focus on minimizing the abuse of controlled substances, increasing adoption of e-prescribing, government initiatives and incentive programs to increase the adoption of e-prescribing solutions.
Web and Cloud based solutions is the largest segment of the ePresciribng market, by delivery mode
Based on the mode of delivery, the e-prescribing market is segmented into on-premise and web- and cloudbased models. In 2019, the web- and cloud-based solutions segment accounted for the largest share of the global e-prescribing market. This segment is also projected to register the highest CAGR during the forecast period. The web- and cloud-based model offers improved performance and reliability by avoiding long deployment cycles. It also minimizes upfront investments without incurring high infrastructure costs as the user can access the software from any compatible system using an access ID or username and password. These advantages are supporting the growth of the web- and cloud-based solutions segment.
North America will continue to dominate the ePrescribing market in 2025
In 2019, the large share of this North American region can be attributed to the stringent legislative and accreditation requirements regarding healthcare, high adoption of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of e-prescribing solution providers in the region.
Prominent players in the global e-prescribing market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts (US), NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc. (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: